Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.
about
Nitric oxide synthases in heart failureGRK2 in the heart: a GPCR kinase and beyondMolecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiologyExercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β3-adrenergic receptor-AMP-activated protein kinase signaling pathway.Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.Anti-hypertrophic and anti-oxidant effect of beta3-adrenergic stimulation in myocytes requires differential neuronal NOS phosphorylationβ3-Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation.Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatmentClinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Aerobic exercise inhibits sympathetic nerve sprouting and restores β-adrenergic receptor balance in rats with myocardial infarction.Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.Nebivolol: impact on cardiac and endothelial function and clinical utility.Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthaseSelective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.Regulation of Overnutrition-Induced Cardiac Inflammatory MechanismsChronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal functionTetrahydrobiopterin Protects against Radiation-induced Growth Inhibition in H9c2 Cardiomyocytes.The future: therapy of myocardial protection.Vasodilatory mechanisms of beta receptor blockade.Molecular targets of current and prospective heart failure therapies.Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapyNovel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.β3 -AR and the vertebrate heart: a comparative view.Endothelial dysfunction and vascular disease - a 30th anniversary update.Cardiac salvage by tweaking with beta-3-adrenergic receptors.Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.Nitric oxide: what's new to NO?New and Emerging Therapies and Targets: Beta-3 Agonists.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites.Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.Nebivolol prevents indomethacin-induced gastric ulcer in rats.Top 10 cardiovascular therapies and interventions for the next decade.
P2860
Q26830146-0F7E7A7E-D82F-4C97-8EED-845FC218FD99Q26851548-8F38F22F-AF20-43EC-8DFA-AF00492E0635Q27023508-AC412799-E4C0-4BBC-929A-E5CC62FB028DQ33594518-3F9AE2FE-F784-4A3F-BEB8-5ACCAC55BAA8Q33645780-8A9CD102-3BCF-4581-896B-D2E9FDD14C75Q33697159-396363EB-C31E-4DAD-A299-1C6C933807E5Q33727126-761DF89B-47D4-47F4-9237-14BBDA62DC43Q33807046-56BB923F-7DD3-46A9-A157-0E469CB257A7Q33827278-B505A814-6C9B-4BB2-A22C-E4C0D1BE5DAEQ34609451-48933A7F-8E50-4DDE-B596-1F4F06D2832CQ35171190-E2E65F78-0B83-4556-A246-9F085D7C6CAAQ35217259-464F693D-262A-496A-959F-4546AF8E2181Q35810063-323D80C0-0400-4475-A9FD-556CD04022A2Q35846698-3E24D472-74F7-4038-BD5E-AFE3E6B109CDQ36006132-0FFA2B28-C8FB-43E2-9E21-51521061C671Q36106686-C2AAD3D6-2022-4E56-84A6-8FDACB6D55F0Q36206138-AC918516-750D-496A-8568-5AC6F6E11D2EQ36629698-5D58153B-3D98-4E2B-857D-FBAE1FB16D26Q36895184-2C6D2884-7FEF-42B1-8320-E4049C132291Q37026891-03900210-F3C3-470F-93BA-8FF1093B4FCBQ37090170-C4956F44-A119-4B9E-AEFB-7858A8AA31F7Q37201204-E5399DBB-4E06-4DBC-BA91-0941BAB2B9ADQ37447507-9FC02BA8-DA3C-4128-B4E7-D8B90C9788CFQ38006737-558B3020-FC68-485E-A5F4-B32CB705C294Q38013691-4582C2FC-F1BA-49EF-A6A1-FB50F571E5DEQ38076688-2E29F130-FBFE-426A-9989-37E1134A37EFQ38153376-7FA5BBB2-C7A1-4297-A90C-1CA8B879F5E8Q38191314-783FC7BF-4E1F-4EF9-AB81-AFD99493B8BAQ38391176-5A727CC2-B5B4-4271-9CFD-FEC847EE97FFQ38680112-1E98D594-FF3B-4C76-8EFC-2940F7D99F18Q38784206-E99E00F1-0545-4C3E-A3F4-EBE4706DCEB7Q38974127-566BCCBB-CEE3-4DC8-8A88-24828044C703Q39038560-7308A6E4-EBCB-4695-B690-83AC0105164AQ39062830-0B540A8F-468D-48FB-9700-21DD14B8370BQ39080324-85F3CA0E-E469-4A88-81AD-3D15151856BEQ45418272-C15E7814-7C28-4C04-9925-D854DA17B9ADQ45941940-F9235935-6BD1-4AFD-BD5B-2341CCAEFDEAQ46268179-B71497C6-F428-447D-A3FD-23F8F99BB149Q46891797-2900313D-B2B5-4E12-9123-B52EEBC5E551Q48778308-557A53D5-FE5A-477D-BC0F-9E5EAB49E09C
P2860
Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@ast
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@en
type
label
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@ast
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@en
prefLabel
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@ast
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@en
P2093
P2860
P1476
Beta3-adrenoreceptor stimulati ...... ric oxide synthase activation.
@en
P2093
Benjamin L Predmore
D Bennett Grinsfelder
David J Lefer
Harold M Wright
Juan P Aragón
Lili A Barouch
Madhav Lavu
Marah E Condit
Sandeep S Patel
Saurabh Jha
P2860
P304
P356
10.1016/J.JACC.2011.09.033
P407
P577
2011-12-01T00:00:00Z